Enhance your knowledge, skills and practice in molecular testing, emerging therapies, and targeted treatments in R/R #AML with this vodcast series hosted by Prof. Amer Zeidan.

All episodes available now 👉 buff.ly/ro4GLtX

#OncSky #HaemSky #MedEd

Shameless plug for my daughter while we watch #NWSL Eat your Arugula boys and girls! youtube.com/shorts/l_7Iu... #cansky #oncsky

SARS-CoV-2 infection heightens the risk of developing HPV-related carcinoma in situ and cancer This study aims to investigate the impact of SARS-CoV-2 infection on HPV-related cancer and carcinoma in situ. We utilized data from TriNetX, a database encompassing 106 healthcare organizations spanning 15 countries and comprising information from ...

starting to see the long-term effects of COVID-19. pmc.ncbi.nlm.nih.gov/articles/PMC... #BlueSky #MedSky #OncSky #SciSky #NurseSky #EMSky

Intralesional IL-2 promising in cutaneous squamous cell carcinoma Intralesional treatment with interleukin-2 therapy elicits a high rate of complete responses in people with cutaneous squamous cell carcinoma.

#MedNews - Intralesional treatment with interleukin-2 therapy elicits a high rate of complete responses in people with cutaneous squamous cell carcinoma.

Full story 👉 buff.ly/Cm9Keyo

#OncSky #SSC

3 reasons appendix cancer is hard to diagnose  Appendix cancer is now known to be distinct from colorectal cancer. But it can still be difficult to diagnose. Why? Gastrointestinal oncologists John Paul Shen, M.D. and Beth Melmink, M.D., weigh in.

Drs. John Paul Shen and Beth Helmink recently shared why appendix cancer can be difficult to diagnose.

Read their insights here: spr.ly/63320B6UtIC #OncSky #Endcancer

It's a tragedy that so many #oncsky and #cansky folks do not know about using gel/ice packs while getting your infusion helps prevent some of the nerve damage / neuropathy. My wife was 4-5 months in before she found out and that's using Scharr in VA and Johns Hopkins. They just fail to mention it

Gotta do what you can. This new chemo (Gem/Tax) is beating her down. #oncsky #cansky

Today, April 3, marks the first-ever #OncologyPharmacistDay! It's the perfect day to acknowledge the two esteemed oncology pharmacists at the UW–Madison School of Pharmacy: Professor Paul Hutson and Associate Professor Lisa Holle (BS ’93, PharmD ’95). #PharmSky #OncSky

Efficacy of venetoclax-obinutuzumab treatment in achieving remission of acquired von Willebrand syndrome in chronic lymphocytic leukemia Acquired von Willebrand syndrome represents a rare but significant complication of chronic lymphocytic leukemia. This patient achieved remission after treatment with venetoclax plus obinutuzumab.

#MedCase - Acquired von Willebrand syndrome represents a rare but significant complication of chronic lymphocytic #leukemia.

This patient achieved remission after treatment with #venetoclax plus #obinutuzumab.

👉 buff.ly/2QrQ0LE

#OncSky

Stage IV cervical cancer survivor thankful for immunotherapy clinical trial Paulette Burkhart was 70 when she was diagnosed with stage IV cervical cancer. Here she shares why she’s glad she enrolled in an immunotherapy clinical trial at UT MD Anderson and encourages others facing cancer to ask about clinical trials as well.

When Paulette Burkhart was diagnosed with advanced cervical cancer, she met with Dr. Roni Wilke, who told her about an immunotherapy clinical trial.

Two years later, the cancer has had a complete response, and Paulette is doing well: spr.ly/63324B6oFt6 #OncSky #EndCancer

Hormonal management after risk-reducing surgery in BRCA-mutated triple-negative breast cancer survivors Is HRT appropriate after risk-reducing surgery in BRCA mutation carriers with a history of triple-negative breast cancer? What do current international guidelines, evidence, and expert…

Is #HRT appropriate after risk-reducing surgery in BRCA mutation carriers with a history of triple-negative #BreastCancer?

Find out what current international guidelines, evidence, and expert recommendations suggest.

👉 buff.ly/lRxlx9q

#OncSky

Radiation therapy improves outcomes for 'supermassive' bile duct tumors A new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialized high-dose type of radiation delivery may significantly improve outcomes for patients with large bile duct tumors in the liver, known as intrahepatic cholangiocarcinoma.

A new study found that a specialized high-dose type of radiation delivery may significantly improve outcomes for patients with intrahepatic cholangiocarcinoma, when given with standard-of-care chemotherapy.

Learn more: spr.ly/6019B6ovs5 #OncSky #EndCancer

My daughter wants you to eat gooseberries. lol. thanks to all of you who watched her short already. She's helping out in her Mom's (my wife) garden since her Mom is battling Leiomyosarcoma. youtube.com/shorts/tpj8u... #kidsgarden #cansky #oncsky #gardeningtips

"Val-YOU-Based-Care" Episode 1: Dr Kimberly Ku discusses "#tacticalEmpathy" in #oncology. Learn how negotiation techniques from the FBI apply to clinical patient communication.

Read the review and listen to the full episode here: https://bit.ly/4rQ3lS5

#MedEd #OncSky

Researchers from UT MD Anderson developed a first-in-class antibody that targets a protein over expressed in many cancer types, allowing for the creation of a new treatment that brings targeted radiation directly to tumor cells.

Learn more: spr.ly/6013B6o6uJ #OncSky #EndCancer

Lung cancer survivor finds care, support and connection at UT MD Anderson After Daniel West was diagnosed with lung cancer, he chose UT MD Anderson for his treatment.

“We liked that at UT MD Anderson, we were able to talk to all my doctors in the beginning," recalls Daniel West. "Lung cancer is such a serious diagnosis, so I liked that they had a plan for my treatment.”

Read his story: spr.ly/63320B6Wt4k #OncSky #EndCancer

Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial In patients with resectable oesophageal squamous cell carcinoma, robot-assisted oesophagectomy was non-inferior, and seemed superior, to thoracoscopic oesophagectomy in terms of 5-year overall surviva...

🆕 Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial

www.thelancet.com/journals/lan...

#GastroSky #OncSky #SurgSky

Anti-Inflammatory Diet Index (AIDI) and Bladder Cancer Risk by Stage: A 22-Year Prospective Swedish Cohort Study (1998–2020) Abstract. Background: Dietary patterns influencing systemic levels of inflammation have been proposed and investigated as possible determinants of cancer risk. We evaluated the association between the...

New in @theaacr.bsky.social: "In this large cohort with 22 years of follow-up, higher Anti-Inflammatory Diet Index scores were associated with lower bladder cancer risk, especially for muscle-invasive disease."🍒 #bladdercancer #oncology #cansky #oncsky #oncosky
aacrjournals.org/cebp/article...

Good thing that's not what is happening....

The HPV vaccine is the L1 gene product, which self assembles into a virus like particle. There's no E6 protein in the HPV vaccines.

The person posting this on social media sites is an oncologist at @warrenalpertmed.bsky.social - #OncSky + #MedSky.

Gleason score decoded: What it means, and how it helps guide prostate cancer treatment A Gleason score is a grading system used for prostate cancer. Pathologists derive the score after looking at prostate tissue samples under a microscope. Lisly Chéry, M.D., breaks down how Gleason scores are calculated how they’re used to guide prostate cancer treatment.

Many physicians use Gleason score and a corresponding Grade Group to grade prostate cancer and to determine the risk of spreading.

Dr. Lisly Chéry shares how your Gleason score can range from 6 to 10 and what those scores can potentially mean: spr.ly/63322B6mpVk #OncSky #EndCancer

#Endocrine #complications occur in 40–60% of survivors of #cancer and include hypothalamic–pituitary disorders, dysregulation of steroid and peptide hormones, and dysregulation of bone and metabolism thelancet.com/journals/lan...
#OpenAccess

#MedSky #EndoSky #OncSky

Aberrant hormone receptors regulate a wide spectrum of endocrine tumors Aberrant G-protein coupled receptor (GPCR) expression is highly prevalent in cortisol-secreting primary bilateral macronodular adrenal hyperplasia (PBMAH) and unilateral adenomas. The aberrant express...

Aberrant or ectopic hormone receptors and their ligands play a much wider role than appreciated in regulating hormonal secretion via endocrine, paracrine, and autocrine modes in many #endocrine #tumours thelancet.com/journals/lan...
#GPCRs

#MedSky #EndoSky #OncSky

Today, we celebrate the people who carry the weight of healthcare on their shoulders.

Physicians don’t just treat patients, they navigate broken systems and impossible expectations.

And still… they show up. That’s resilience. We see you.

#NationalDoctorsDay #medsky #oncsky #patients #nursesky

Age at retinoblastoma diagnosis aids genetic risk stratification for bilateral conversion Considering age at diagnosis alongside genetic risk stratification could help identify children with unilateral retinoblastoma who are likely to convert to metachronous bilateral disease.

#MedNews - Considering age at diagnosis alongside genetic risk stratification could help identify children with unilateral #retinoblastoma who are likely to convert to metachronous bilateral disease.

Full story 👉 buff.ly/eOhxbm8

#EyeSky #OncSky

Leukopenia: 6 things to know about a low white blood cell count What’s the most common reason for a low white blood cell count? Transfusion specialist Joanne Becker, M.D., answers this and five other questions about leukopenia.

Leukopenia is the scientific term for having a low white blood cell count – but its treatment depends more on symptoms than blood count numbers.

Dr. Joanne Becker explains: spr.ly/63323B6YtqJ #OncSky #EndCancer

It's a beautiful day to add an informatician to your Bluesky feed!

#MedSky #PedSky #RadSky #IDSky #OncSky #PublicHealth #HealthEquity #DigitalHealth #HealthIT

GLP-1 drugs may improve survival of people with brain metastases People with cancer brain metastases and type 2 diabetes might derive a survival benefit from the use of glucagon-like peptide-1 receptor agonists.

#MedNews - People with cancer brain metastases and #T2D might derive a survival benefit from the use of #GLP1 receptor agonists.

Full story 👉 buff.ly/xtsSB6c

#OncSky

Many Older Adults With Cancer Prioritize Quality of Life Over Survival Most older adults with advanced cancer would rather prioritize preserving quality of life vs prolonging survival, but these preferences may not be taken into account, a study published in JAMA Oncolog...

Most #olderadults w/advanced #cancer would rather prioritize preserving #QualityOfLife vs prolonging survival. However, study findings point to a lack of responsiveness to #patient priorities. jamanetwork.com/journals/jama/fullarticle/2847169

#MedSky #OncSky #CanSky #PatientExperience #PublicHealth

Cardiovascular health assessed by Life’s Essential 8 score, genetic risk, colonoscopy status, and risk of colorectal cancer: an analysis of UK Biobank Objective Colorectal cancer (CRC) and cardiovascular disease (CVD) share common risk factors. This study explores the association between cardiovascular health (CVH), assessed using the Life’s Essenti...

New in @bmj.com: "Better CVH is associated with a reduced risk of CRC, particularly in individuals with high genetic susceptibility and those without a history of colonoscopy screening." #colorectalcancer #cardiosky #cansky #oncology #oncsky #cardiology
bmjopengastro.bmj.com/content/13/1...

Cholangiocarcinoma is often diagnosed late — but 40–50% of patients may have actionable mutations

In our latest podcast, we explore the case for early molecular testing and the role of the MDT in expanding treatment options | 🎧 Listen: t.ly/J_Wv2
#oncology #MedEd #BTC #BillaryTractCancers #OncSky